CTY · Insider Trading

City Therapeutics, Inc. Common Stock

Every open-market purchase and sale reported by CTY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
7
most recent
Open-Market Buys
0
code P
Sales
0
code S
Reporting Insiders
3
current holders
CTY — Recent Form 4 Transactions (latest 2026-10-19)
FiledInsiderRole TypeSharesValue
2026-10-19 Sara Nochur Director A +22,649 deriv. —
2026-10-19 Ron M Philip Director A +22,649 deriv. —
2026-10-19 John Maraganore Director C +610,759 —
2026-10-19 Andrew C. Orth President & CEO A +77,979 deriv. —
2026-10-19 Barry E Greene Director A +22,649 deriv. —
2026-10-19 Robert Nelsen Director MIXED +10,974,215 +$3.06M
2026-10-19 Kristina Burow 10%+ Owner MIXED +65,845,290 +$18.36M
CTY — Current Insider Holders
InsiderRole Shares HeldValue
Robert Nelsen Director 13,522,507 —
Kristina Burow 10%+ Owner 6,013,192 —
John Maraganore Director 1,789,199 —
CTY Insider Trading FAQ
Who are the insiders at CTY?
3 officers, directors and 10%+ beneficial owners currently report holdings in CTY via SEC Form 4.
Are CTY insiders buying or selling?
Across the 7 most recent Form 4 filings for CTY, 0 were open-market purchases (code P) and 0 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is CTY insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent CTY filing is dated 2026-10-19.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the CTY quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.